XFOR (X4 Pharmaceuticals) Short-term investments


XFOR X4 Pharmaceuticals Inc XFOR
24 GF Score
Price $3.96
! 5 Warning Signs
View Full Analysis

What is X4 Pharmaceuticals Short-term investments?

Short-term investments only applies to insurance companies.

XFOR
24GF Score
X4 Pharmaceuticals Inc XFOR
Short-term investments is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

X4 Pharmaceuticals Business Description

Address 61 North Beacon Street, 4th Floor, Boston, MA, USA, 02134
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. The Company's clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
24GF Score

Get the complete analysis for XFOR

Short-term investments is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.96
Price